Humana has a P/E ratio of 16.4 based on its 12 month trailing earnings per share of $14.17. Considering its future earnings ...

Other health insurers in the S&P 500, including Humana, Molina Healthcare and Cigna, saw their stock prices decline. Companies in the broader healthcare space, including Elevance Health, Centene and ...

Financial markets have been volatile, but a comparison of how the stock market and other leading asset classes are behaving to other recession periods shows traders are not yet pricing in a recession.

The standing of Humana among financial experts is revealed through an in-depth exploration of recent analyst actions. The ...

Delving into the details, we found 44% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we ...

the market reacted positively. In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook. According to InvestingPro ...

US stocks dropped as Wall Street braced for a busy day of Big Tech earnings and digested President Trump's latest move on tariffs.

Despite the outperformance, the payer’s stock was largely flat following the earnings release — a market reaction that ...

Welcome to Humana's First Quarter 2025 Earnings Call ... there are no changes to our membership guidance for 2025. We had strong performance in OEP, and the early outlook for the rest of the ...